Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest ranitidine Stories

2013-09-09 12:25:11

RIDGEFIELD, Conn., Sept. 9, 2013 /PRNewswire/ -- Zantac®, a trusted name in heartburn relief and the #1 doctor recommended over-the-counter H2-blocker, today announced the introduction of Captain Zantac(TM), the new face of Boehringer Ingelheim Consumer Health Care's ZANTAC brand. Captain Zantac, a miniature animated fire captain, and his firefighter crew will help heartburn sufferers everywhere find solutions that leave them relieved and satisfied. (Photo:...

2013-04-05 08:23:20

Drugs Include Nilandron®, Plaquenil®, Rilutek®, Uroxatral®, and Kayexalate® CARY, N.C., April 5, 2013 /PRNewswire/ -- Covis Pharmaceuticals, Inc. announced an agreement today to distribute Nilandron(®) (nilutamide), Plaquenil(®) (hydroxychloroquine), Rilutek(®) (riluzole), Uroxatral(®) (alfuzosin hydrochloride) and Kayexalate(®) (sodium polystyrene sulfate) in the United States.The products cover a broad array of treatments and disease states:...

2012-03-29 02:26:27

CARY, N.C., March 29, 2012 /PRNewswire/ -- Covis Pharmaceuticals, Inc. announced today that Zantac® (ranitidine hydrochloride) Injection is once again widely available for therapeutic use throughout the United States and Puerto Rico. The company launched last year as a distributor for a product portfolio that addresses life threatening and other serious medical conditions in the cardiovascular, central nervous system and acute care markets. "Covis was formed to reliably provide critical...

2011-05-16 10:27:00

ALLEGAN, Mich., May 16, 2011 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application for over-the-counter (OTC) Ranitidine 150 (regular and cool mint), a generic version of Zantac 150®. We expect to launch early in our fiscal 2012. Zantac 150 (ranitidine) is indicated for the relief of heartburn associated with acid indigestion and sour...

2011-01-27 07:24:00

HARBIN, China, Jan. 27, 2011 /PRNewswire-Asia/ -- Weikang Bio-Technology Group Co., Inc. (OTC Bulletin Board: WKBT) ("Weikang" or the "Company"), a leading developer, manufacturer and marketer of Traditional Chinese Medicine (TCM), Western prescription and OTC pharmaceuticals and other health and nutritional products in the People's Republic of China, today announced that one of its products, Ranitidine Hydrochloride Capsule, has been added to the National Drug Reimbursement List ("NDRL")...

2010-12-03 15:53:30

YANG Nan, MAO ZongWan and SUN HongZhe et al., at the Department of Chemistry, University of Hong Kong and Sun Yat-sen University have characterized a series of bismuth citrate complexes by X-ray crystallography and modeled the structure of ranitidine bismuth citrate, a medicine used widely for the treatment of peptic ulcer and gastric reflux disease. The polymeric framework of bismuth citrate may serve as a "drug carrier" for delivery of other drugs in the human body. This significant...

2010-02-04 16:07:00

TORONTO, Feb. 4 /PRNewswire/ - To view this Social Media Release, please enter the following address in your web browser. http://smr.newswire.ca/en/mcneil-consumer-healthcare/zantac-chili-challenge SOURCE CNW Social Media

2009-11-17 17:14:00

ORLANDO, Fla., Nov. 17 /PRNewswire-USNewswire/ -- Today the FDA notified healthcare professionals of new safety information concerning a drug interaction between clopidogrel, an anti-clotting medication, and omeprazole, a proton pump inhibitor (PPI) used to reduce stomach acid. The FDA notes that they have new data showing that when healthy volunteers received clopidogrel with omeprazole, clopidogrel was less effective in its anti-clotting action than when given without omeprazole. The...

2009-10-08 08:12:49

H2 Blocker drugs, such as Famotidine, Cimetidine and Ranitidine, approved in the U.S. for acid reflux (heartburn), pose no significant risks for the fetus according to a large collaborative cohort study by researchers at Ben-Gurion University of the Negev. The study published in the Journal of Clinical Pharmacology provides significant reassurance for the safety of the fetus when H2 blocker drugs are given to women to relieve acid reflux during pregnancy. H2 blockers are among the most...

2009-09-16 15:38:54

U.S. researchers suggest doctors may wish to limit acid reducer use for their ventilator patients. The study, published in Chest, also recommends if an acid reducer is needed, less powerful ranitidine -- Zantac, which inhibits gastric acid secretion -- be used. The analysis of 834 cardiothoracic surgery patients finds those on another popular stomach acid reducer -- pantoprazole -- are three times more likely to develop pneumonia. Acid-reducing drugs can make the stomach a more hospitable...